Probiotics and prebiotics: Effects on diarrhea

被引:170
作者
de Vrese, Michael [1 ]
Marteau, Philippe R.
机构
[1] Fed Res Ctr Nutr & Food, Inst Physiol & Biochem Nutr, D-24103 Kiel, Germany
[2] Hop Lariboisiere, F-75010 Paris, France
关键词
D O I
10.1093/jn/137.3.803S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Probiotics have preventive as well as curative effects on several types of diarrhea of different etiologies. Prevention and therapy (or alleviation) of diarrhea have been successfully investigated for numerous dietary probiotics to establish probiotic properties and to justify health claims (the medicinal use of probiotic food and the therapy of gastrointestinal diseases itself may not be advertised under current food laws). Other probiotic microorganisms (e.g., Lactobacillus rhamnosus GG, L. reuteri, certain strains of L. casei, L. acidophilus, Escherichia coli strain Nissle 1917, and certain bifidobacteria and enterococci (Enterococcus faecium SF68) as well as the probiotic yeast Saccharomyces boulardii have been investigated with regard to their medicinal use, either as single strains or in mixed-culture probiotics. However, the effects on humans have been assessed mainly in smaller (n < 100) randomized, controlled clinical studies or in open label trials, but large intervention studies and epidemiological investigations of long-term probiotic effects are largely missing. Perhaps with the exception of nosocomial diarrhea or antibiotic-associated diarrhea, the results of these studies are not yet sufficient to give specific recommendations for the clinical use of probiotics in the treatment of diarrhea.
引用
收藏
页码:803S / 811S
页数:9
相关论文
共 135 条
[61]   Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea:: A systematic review [J].
Hawrelak, JA ;
Whitten, DL ;
Myers, SP .
DIGESTION, 2005, 72 (01) :51-56
[62]  
HEIMBURGER DC, 1994, NUTRITION, V10, P392
[63]  
Hilton, 1997, J Travel Med, V4, P41, DOI 10.1111/j.1708-8305.1997.tb00772.x
[64]   Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats [J].
Holma, R ;
Juvonen, P ;
Asmawi, MZ ;
Vapaatalo, H ;
Korpela, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (09) :1042-1047
[65]   Efficacy of probiotic use in acute diarrhea in children - A meta-analysis [J].
Huang, JS ;
Bousvaros, A ;
Lee, JW ;
Diaz, A ;
Davidson, EJ .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (11) :2625-2634
[66]   Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection [J].
Hudault, S ;
Lievin, V ;
BernetCamard, MF ;
Servin, AL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1997, 63 (02) :513-518
[67]   Controlled trial of oligofructose in the management of irritable bowel syndrome [J].
Hunter, JO ;
Tuffnell, Q ;
Lee, AJ .
JOURNAL OF NUTRITION, 1999, 129 (07) :1451S-1453S
[68]   IMPROVED IMMUNOGENICITY OF ORAL DXRRV REASSORTANT ROTAVIRUS VACCINE BY LACTOBACILLUS-CASEI GG [J].
ISOLAURI, E ;
JOENSUU, J ;
SUOMALAINEN, H ;
LUOMALA, M ;
VESIKARI, T .
VACCINE, 1995, 13 (03) :310-312
[69]  
ISOLAURI E, 1991, PEDIATRICS, V88, P90
[70]  
Jirapinyo Pipop, 2002, Journal of the Medical Association of Thailand, V85, pS739